Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective

Area of Science:

• Biochemistry
• Metabolomics
• Neuroscience

Background:

• Lipidomics provides comprehensive analysis of lipids in biological systems.
• Technological advancements in mass spectrometry, NMR, and chromatography have improved lipid profiling.
• Altered lipid profiles are observed in various diseases, including schizophrenia.

Purpose of the Study:

• To illustrate the contribution of lipidomics to understanding schizophrenia's biological mechanisms.
• To highlight the relevance of lipids as biomarkers for schizophrenia.
• To discuss future perspectives of lipidomics in mental disorders.

Main Methods:

• Lipid-targeted metabolomics approach.
• Utilizing advancements in mass spectrometry, nuclear magnetic resonance spectroscopy, and chromatography.
• Application of lipidomics in clinical studies.

Main Results:

• Lipidomics can provide insights into the specific roles of lipid molecular species in health and disease.
• Lipidomics supports the identification of potential biomarkers for preventive or therapeutic strategies.
• Clinical lipidomics studies offer new insights into lipid profiling and pathophysiological mechanisms of schizophrenia.

Conclusions:

• Lipidomics is a valuable tool for understanding the biological mechanisms of schizophrenia.
• Lipids serve as relevant biomarkers for schizophrenia, aiding in diagnosis and treatment.
• Future applications of lipidomics hold promise for advancing the understanding and treatment of mental disorders.